Rigel Pharmaceuticals (RIGL) EBITDA (2010 - 2026)
Rigel Pharmaceuticals' quarterly EBITDA came in at $11.9 million in Q1 2026, down 6.95% year-on-year from $12.8 million in Q1 2025, and down 48.71% quarter-over-quarter from $23.2 million in Q4 2025.
Rigel Pharmaceuticals has reported EBITDA for 17 years, with the latest figure at $11.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 6.95% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $124.6 million (up 183.58% YoY), and the FY2025 full-year result was $125.5 million, up 418.63% from the prior year.
- EBITDA for Q1 2026 stood at $11.9 million, down from $23.2 million in the prior quarter.
- The five-year high for EBITDA was $61.1 million in Q2 2025, with the low at -$26.3 million in Q1 2022.
- Average EBITDA over 5 years is $5.0 million, with a median of $2.0 million recorded in 2023.
- Year-over-year, EBITDA plunged 162.89% in 2022 and soared 13569.57% in 2025.
- Tracing RIGL's EBITDA over 5 years: stood at $2.1 million in 2022, then dropped by 5.44% to $2.0 million in 2023, then soared by 747.15% to $16.7 million in 2024, then soared by 39.12% to $23.2 million in 2025, then plunged by 48.71% to $11.9 million in 2026.
- The last three EBITDA figures came in at $11.9 million (Q1 2026), $23.2 million (Q4 2025), and $28.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 11.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 28.42 Mn |
| Jun 30, 2025 | 61.10 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Sep 30, 2024 | 14.06 Mn |
| Jun 30, 2024 | 447,000.00 |
| Mar 31, 2024 | -6.97 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | -4.47 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -12.73 Mn |
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | -18.40 Mn |
| Jun 30, 2022 | -12.97 Mn |
| Mar 31, 2022 | -26.26 Mn |
| Dec 31, 2021 | -21.42 Mn |
| Sep 30, 2021 | -19.79 Mn |
| Jun 30, 2021 | -13.05 Mn |
| Mar 31, 2021 | 41.76 Mn |
| Dec 31, 2020 | -18.83 Mn |
| Sep 30, 2020 | -13.78 Mn |
| Jun 30, 2020 | -17.39 Mn |
| Mar 31, 2020 | 21.03 Mn |
| Dec 31, 2019 | -17.34 Mn |
| Sep 30, 2019 | -12.04 Mn |
| Jun 30, 2019 | -21.34 Mn |
| Mar 31, 2019 | -18.38 Mn |
| Dec 31, 2018 | 2.53 Mn |
| Sep 30, 2018 | -24.37 Mn |
| Jun 30, 2018 | -26.11 Mn |
| Mar 31, 2018 | -24.39 Mn |
| Dec 31, 2017 | -26.22 Mn |
| Sep 30, 2017 | -17.86 Mn |
| Jun 30, 2017 | -19.34 Mn |
| Mar 31, 2017 | -16.20 Mn |
| Dec 31, 2016 | -15.79 Mn |
| Sep 30, 2016 | -22.74 Mn |
| Jun 30, 2016 | -13.65 Mn |
| Mar 31, 2016 | -17.57 Mn |
| Dec 31, 2015 | -12.75 Mn |
| Sep 30, 2015 | -6.78 Mn |
| Jun 30, 2015 | -13.97 Mn |
| Mar 31, 2015 | -18.24 Mn |
| Dec 31, 2014 | -22.37 Mn |
| Sep 30, 2014 | -20.97 Mn |
| Jun 30, 2014 | -25.39 Mn |
| Mar 31, 2014 | -22.31 Mn |
| Dec 31, 2013 | -16.94 Mn |
| Sep 30, 2013 | -23.93 Mn |
| Jun 30, 2013 | -22.89 Mn |
| Mar 31, 2013 | -25.58 Mn |
| Dec 31, 2012 | -25.62 Mn |
| Sep 30, 2012 | -25.57 Mn |
| Jun 30, 2012 | -24.88 Mn |
| Mar 31, 2012 | -23.31 Mn |
| Dec 31, 2011 | -25.91 Mn |
| Sep 30, 2011 | -18.04 Mn |
| Jun 30, 2011 | -21.56 Mn |
| Mar 31, 2011 | -20.86 Mn |
| Dec 31, 2010 | -19.67 Mn |
| Sep 30, 2010 | 50.36 Mn |
| Jun 30, 2010 | 26.98 Mn |